Background We aimed to describe the current rates of inappropriate empirical antibiotic
treatment (IEAT) in oncohematological patients with febrile neutropenia (FN) and its impact …

Background There is currently no consensus on optimal duration of antibiotic treatment in
febrile neutropenia. We report on the clinical impact of implementation of antibiotic de …

Objectives We aimed to describe the current time-to-positivity (TTP) of blood cultures in
individuals with onco-haematological diseases with febrile neutropenia. We assessed the …

Background Initial management of chemotherapy-induced febrile neutropaenia (FN)
comprises empirical therapy with a broad-spectrum antimicrobial. Currently, there is …

Owing to increasing resistance and the limited arsenal of new antibiotics, especially against
Gram-negative pathogens, carefully designed antibiotic regimens are obligatory for febrile …

Background Continuation of empirical antimicrobial therapy (EAT) for febrile neutropenia in
patients with haematological malignancies until neutrophil recovery could prolong the …

Febrile neutropenia (FN) is the main reason for antibiotic prescription in hematology wards
where, on the other hand, antibiotic stewardship (AS) is poorly explored. The objectives of …

Progress has been made in the development and validation of rules that attempt ito predict a
low risk (< 10%) of severe infection or clinical complications in patients with cancer, fever …

Introduction: Immediate empirical antibiotic therapy is mandatory in febrile chemotherapy-
induced neutropenia, but its optimal duration is unclear, especially in patients with fever of …

Background Febrile neutropenia is an oncologic emergency. The timing of antibiotics
administration in patients with febrile neutropenia may result in adverse outcomes. Our study …